- Home
- INTS vs MTEN Comparison
INTS vs MTEN Comparison
Compare INTS & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTS | MTEN |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 1.5M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | INTS | MTEN |
|---|---|---|
| Price | $4.90 | $1.03 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 28.8K | 28.5K |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.02 |
| 52 Week High | $8.06 | $26.03 |
Technical Indicators
Market Signals| Indicator | INTS | MTEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.08 | 35.05 |
| Support Level | $0.29 | $0.90 |
| Resistance Level | $8.06 | $1.35 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 20.29 | 45.51 |
Price Performance
Historical ComparisonAbout INTS Intensity Therapeutics Inc.
Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.